S8B); this contrasted with mice that received anakinra starting at 1-week post-inoculation, suggesting that inhibiting IL-1α signaling at the precancer stage/during tumor initiation is a unique opportunity to derail lung tumor growth. This evidence concerns the gene IL1A and neoplasm.